BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Adam R, Del Gaudio M. Evolution of liver transplantation for hepatocellular carcinoma. J Hepatol. 2003;39:888-895. [PMID: 14642602 DOI: 10.1016/j.jhep.2003.10.003] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
Number Citing Articles
1 Cabibbo G, Latteri F, Antonucci M, Craxì A. Multimodal approaches to the treatment of hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol 2009;6:159-69. [DOI: 10.1038/ncpgasthep1357] [Cited by in Crossref: 48] [Cited by in F6Publishing: 50] [Article Influence: 3.7] [Reference Citation Analysis]
2 Burroughs A, Hochhauser D, Meyer T. Systemic treatment and liver transplantation for hepatocellular carcinoma: two ends of the therapeutic spectrum. The Lancet Oncology 2004;5:409-18. [DOI: 10.1016/s1470-2045(04)01508-6] [Cited by in Crossref: 117] [Cited by in F6Publishing: 44] [Article Influence: 6.5] [Reference Citation Analysis]
3 Pipili C, Cholongitas E. Treatment of chronic hepatitis C in liver transplant candidates and recipients: Where do we stand? World J Hepatol 2015; 7(12): 1606-1616 [PMID: 26140081 DOI: 10.4254/wjh.v7.i12.1606] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
4 Zavaglia C, De Carlis L, Alberti AB, Minola E, Belli LS, Slim AO, Airoldi A, Giacomoni A, Rondinara G, Tinelli C. Predictors of long-term survival after liver transplantation for hepatocellular carcinoma. Am J Gastroenterol. 2005;100:2708-2716. [PMID: 16393224 DOI: 10.1111/j.1572-0241.2005.00289.x] [Cited by in Crossref: 176] [Cited by in F6Publishing: 168] [Article Influence: 11.0] [Reference Citation Analysis]
5 Zhu R, Weng D, Lu S, Lin D, Wang M, Chen D, Lv J, Li H, Lv F, Xi L, Zhou J, Ma D, Li N. Double-Dose Adenovirus-Mediated Adjuvant Gene Therapy Improves Liver Transplantation Outcomes in Patients with Advanced Hepatocellular Carcinoma. Human Gene Therapy 2018;29:251-8. [DOI: 10.1089/hum.2017.114] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
6 Grat M, Kornasiewicz O, Hołówko W, Lewandowski Z, Zieniewicz K, Paczek L, Krawczyk M. Evaluation of total tumor volume and pretransplantation α-fetoprotein level as selection criteria for liver transplantation in patients with hepatocellular cancer. Transplant Proc 2013;45:1899-903. [PMID: 23769067 DOI: 10.1016/j.transproceed.2012.12.010] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
7 Ismail H, Broniszczak D, Kaliciński P, Markiewicz-Kijewska M, Teisseyre J, Stefanowicz M, Szymczak M, Dembowska-Bagińska B, Kluge P, Perek D, Kościesza A, Dzik E, Lembas A, Teisserye M. Liver transplantation in children with hepatocellular carcinoma. Do Milan criteria apply to pediatric patients? Pediatr Transplant 2009;13:682-92. [PMID: 19496985 DOI: 10.1111/j.1399-3046.2009.01062.x] [Cited by in Crossref: 56] [Cited by in F6Publishing: 41] [Article Influence: 4.3] [Reference Citation Analysis]
8 Aziz S, Sey M, Marotta P, Driman D, Parfitt J, Teriaky A, Brahmania M, Skaro A, Qumosani K. Recurrent Hepatocellular Carcinoma After Liver Transplantation: Validation of a Pathologic Risk Score on Explanted Livers to Predict Recurrence. Transplant Proc 2021;53:1975-9. [PMID: 34272052 DOI: 10.1016/j.transproceed.2021.05.007] [Reference Citation Analysis]
9 Aljabiri MR, Lodato F, Burroughs AK. Surveillance and diagnosis for hepatocellular carcinoma. Liver Transpl 2007;13:S2-S12. [DOI: 10.1002/lt.21324] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
10 Van Thiel DH, Yong S, Li SD, Kennedy M, Brems J. The development of de novo hepatocellular carcinoma in patients on a liver transplant list: frequency, size, and assessment of current screening methods. Liver Transpl 2004;10:631-7. [PMID: 15108254 DOI: 10.1002/lt.20120] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 1.6] [Reference Citation Analysis]
11 Guerrini GP, Pinelli D, Di Benedetto F, Marini E, Corno V, Guizzetti M, Aluffi A, Zambelli M, Fagiuoli S, Lucà MG, Lucianetti A, Colledan M. Predictive value of nodule size and differentiation in HCC recurrence after liver transplantation. Surgical Oncology 2016;25:419-28. [DOI: 10.1016/j.suronc.2015.09.003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
12 Hübscher SG. Recurrent and de-novo disease in the liver allograft: . Current Opinion in Organ Transplantation 2006;11:283-8. [DOI: 10.1097/01.mot.0000227847.59947.8d] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
13 Talwalkar JA, Gores GJ. Diagnosis and staging of hepatocellular carcinoma. Gastroenterology. 2004;127:S126-S132. [PMID: 15508076 DOI: 10.1053/j.gastro.2004.09.026] [Cited by in Crossref: 88] [Cited by in F6Publishing: 70] [Article Influence: 4.9] [Reference Citation Analysis]
14 Bjøro K, Schrumpf E. Liver transplantation for primary sclerosing cholangitis. J Hepatol. 2004;40:570-577. [PMID: 15030971 DOI: 10.1016/j.jhep.2004.01.021] [Cited by in Crossref: 24] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
15 Stigliano R, Burroughs A. Should we biopsy each liver mass suspicious for HCC before liver transplantation?–No, please don't. Journal of Hepatology 2005;43:563-8. [DOI: 10.1016/j.jhep.2005.07.015] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 2.4] [Reference Citation Analysis]
16 Wiesner RH, Freeman RB, Mulligan DC. Liver transplantation for hepatocellular cancer: the impact of the MELD allocation policy. Gastroenterology. 2004;127:S261-S267. [PMID: 15508092 DOI: 10.1053/j.gastro.2004.09.040] [Cited by in Crossref: 208] [Cited by in F6Publishing: 174] [Article Influence: 11.6] [Reference Citation Analysis]
17 McCaughan GW, Koorey DJ, Strasser SI. Liver transplantation for viral hepatitis. Hosp Med 2005;66:8-12. [PMID: 15686159 DOI: 10.12968/hmed.2005.66.1.17528] [Reference Citation Analysis]
18 McCormack L, Petrowsky H, Clavien PA. Surgical therapy of hepatocellular carcinoma. Eur J Gastroenterol Hepatol 2005;17:497-503. [PMID: 15827439 DOI: 10.1097/00042737-200505000-00005] [Cited by in Crossref: 44] [Cited by in F6Publishing: 39] [Article Influence: 2.6] [Reference Citation Analysis]
19 Hoti E, Adam R. Liver transplantation for primary and metastatic liver cancers. Transpl Int. 2008;21:1107-1117. [PMID: 18713148 DOI: 10.1111/j.1432-2277.2008.00735.x] [Cited by in Crossref: 78] [Cited by in F6Publishing: 58] [Article Influence: 5.6] [Reference Citation Analysis]
20 Bonadio I, Colle I, Geerts A, Smeets P, Berardi G, Praet M, Rogiers X, de Hemptinne B, Van Vlierberghe H, Troisi RI. Liver transplantation for hepatocellular carcinoma comparing the Milan, UCSF, and Asan criteria: long-term follow-up of a Western single institutional experience. Clin Transplant 2015;29:425-33. [DOI: 10.1111/ctr.12534] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]